A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis

NCT03928743 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Bimekizumab
OTHER: Placebo

Sponsor

UCB Biopharma SRL